Overview of Dr. Khalil
Dr. Danny Khalil is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Stony Brook University Health Sciences Center School of Medicine and has been in practice 6 years. He is one of 497 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 30 publications and over 500 citings.
Office
160 East 53rd Street
New York, NY 10022
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2011 - 2014
Stony Brook University Health Sciences Center School of MedicineClass of 2011
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2013 - 2026
NJ State Medical License 2019 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer Start of enrollment: 2018 Oct 17
Publications & Presentations
PubMed
- First-in-human clinical outcomes with NG-350A, an anti-CD40 expressing tumor-selective vector designed to remodel immunosuppressive tumor microenvironments.Aung Naing, Danny Khalil, Oliver Rosen, D Ross Camidge, Tom Lillie
Journal for Immunotherapy of Cancer. 2024-10-15 - Immunologic signatures of response and resistance to nivolumab with ipilimumab in advanced metastatic cancer.Apostolia M Tsimberidou, Farah A Alayli, Kwame Okrah, Alexandra Drakaki, Danny N Khalil
The Journal of Experimental Medicine. 2024-10-07 - 1 citationsClinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapy.Darren Cowzer, Joanne F Chou, Henry Walch, Fergus Keane, Danny Khalil
The Oncologist. 2024-10-03
Press Mentions
Recipients of AACR Research Funding & Fellowships 1993–2017September 8th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
